Jon Isaacsohn
Plus aucun poste en cours
Profil
The founder of CinCor Pharma, Inc. is Jon Isaacsohn.
He held the titles of Director and Chief Scientific Officer at the company in 2021.
Anciens postes connus de Jon Isaacsohn
| Sociétés | Poste | Fin |
|---|---|---|
| CINCOR PHARMA, INC. | Directeur Général | 06/07/2021 |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
